Megan Harper
In December 2025, Boston-based medical imaging startup A2Z Radiology raised $4.5 million in a Seed funding round. The round was led by Khosla Ventures and SeaX Ventures.
Founded by CEO Samir Rajpurkar and co-founder Pranav Rajpurkar, the company also announced a major regulatory milestone: securing FDA clearance for its autonomous triage system.
A2Z Radiology addresses the critical backlog in emergency rooms by automating the analysis of abdomen and pelvis CT scans. Unlike single-condition tools, its “Unified Triage” platform can simultaneously detect multiple urgent findings—such as fractures or internal bleeding—immediately after the scan is taken. This allows radiologists to prioritize life-threatening cases instantly, significantly reducing turnaround times in trauma centers.
The new capital will be used to deploy its FDA-cleared solution in US hospitals and expand its R&D into chest and brain imaging.
Key Details
- Company: A2Z Radiology
- Funding: $4.5M Seed
- Headquarters: Boston, MA
- Lead Investors: Khosla Ventures, SeaX Ventures
- Founders: Samir Rajpurkar (CEO), Pranav Rajpurkar
- Key Milestone: FDA Clearance for Abdomen/Pelvis CT
